V

Varian

Tech-enabled radiation oncology hardware and software

Senior Manager - Global Field Operations, GCN

Full-TimeUpdated on 10/15/2026
No salary listed
Expert
Bachelor's
China
In PersonExpected to travel regionally and internationally up to 50% or greater.
Field ServiceEquipment Field Service

About the job

Requirements
  • A bachelor's degree or equivalent 15 years of related working experience.
  • At least 8–10 years of people management experience or supervisory equivalent.
  • Demonstrated interpersonal communication, listening, time management, problem-solving, leadership, and empathy.
  • Ability to build and maintain effective working relationships with direct reports, management peers, and colleagues.
  • Ability to lead diverse teams and build collaborative, customer-focused teams.
  • Fluency in spoken and written English and Chinese; depending on customer requirements, excellent communication skills and the ability to speak and present publicly in Chinese.
  • Comprehensive understanding of process, technical design, and quality objectives.
  • Proficiency in Microsoft Office applications.
  • Willingness to work flexible hours, including beyond the standard work week.
  • Willingness to work onsite and occasionally coordinate system downtime events from offsite locations.
  • Willingness to travel regionally and internationally up to 50% or greater.
Responsibilities
  • Develop the site service strategy in alignment with APAC and Global GFO business direction, drive high service levels in the proton business, maximize customer satisfaction, and achieve financial objectives.
  • Implement company policies, programs, and guidelines; ensure employee productivity, growth, and training; manage resources; and maintain the business, technical, and external market awareness needed to manage the organization.
  • Adhere to site contractual obligations, ensure deliverables are met, and coordinate with stakeholders to fulfill requirements.
  • Analyze operational processes and escalation procedures, and assess training needs to identify service-delivery improvements and customer value opportunities.
  • Establish customer communications concerning proton equipment and work with contacts within Varian and SHS to address concerns, develop customer strategies, and drive implementation.
  • Lead the team in complying with company and local safety policies.
  • Manage the team, identify development opportunities, plan team development, and coach SGM and management teams at each site.
  • Coordinate with APAC Operations and Engineering to ensure processes, procedures, and scorecards are followed and implemented at the sites, and monitor each site's business performance and profile.
  • Develop the APAC regional business budget plan, manage the established service budget, monitor financial performance, and ensure each site's service revenue, cost, margin, and payment objectives are achieved.
  • Manage customer relations with internal departments on service and maintenance matters to ensure systems are clinically available within contractual timeframes and customers can operate VPS equipment according to technical and safety guidelines.
Desired Qualifications
  • Experience with HCM products such as Workday, CRM products such as Salesforce, and ERP products such as SAP.
  • Project management experience.
  • Knowledge of medical device field service operations.

About the company

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, opening a non-cancer market.
  • Telix collaboration and 2026 AI approvals expand Varian's clinical and software pipeline.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium in May 2026, eroding software differentiation.
  • Elekta still attacks Varian's lead in adaptive radiotherapy and premium MR-guided care.
  • If FLASH and non-oncology bets fail by 2028, Varian becomes a commoditized linear-accelerator vendor.

What makes Varian unique

  • Siemens Healthineers gives Varian imaging, radiotherapy, and capital-sales integration globally.
  • Varian's 2026 CE-marked Eclipse AI contouring deepens workflow lock-in across planning.
  • TrueBeam, Halcyon, and Ethos create an installed-base moat hospitals rarely replace.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

Health Insurance

Dental Insurance

Vision Insurance

Wellness Program

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
Varex Imaging Corporation
Sep 14th, 2026
About Us | Varex Imaging Corporation

We strive to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster

MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.